hematoxylin has been researched along with Renal Insufficiency, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gan, H; Li, L | 1 |
| Ben, Y; Chang, Y; Chen, G; Gao, X; Hao, J; Li, H; Ma, X; Qiang, P; Shimosawa, T; Wang, X; Xiong, Y; Xu, Q; Yang, F | 1 |
2 other study(ies) available for hematoxylin and Renal Insufficiency, Chronic
| Article | Year |
|---|---|
Intact Fibroblast Growth Factor 23 Regulates Chronic Kidney Disease-Induced Myocardial Fibrosis by Activating the Sonic Hedgehog Signaling Pathway.
Topics: Actins; Animals; Collagen Type I; Eosine Yellowish-(YS); Fibroblast Growth Factor-23; Fibrosis; Hedgehog Proteins; Hematoxylin; Rats; Renal Insufficiency, Chronic; RNA, Messenger; Signal Transduction | 2022 |
Eplerenone Prevents Cardiac Fibrosis by Inhibiting Angiogenesis in Unilateral Urinary Obstruction Rats.
Topics: Actins; Aldosterone; Animals; Collagen; Eosine Yellowish-(YS); Eplerenone; Fibrosis; Glucocorticoids; Hematoxylin; Interleukin-1beta; Kidney; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Mineralocorticoid; Renal Insufficiency, Chronic; RNA, Messenger; Ureteral Obstruction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Ventricular Remodeling | 2022 |